SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForesight Ent Regulatory News (FTF)

Share Price Information for Foresight Ent (FTF)

Share Price is delayed by 15 minutes
Get Live Data
46.20    0.00 (0.00%)
Bid:
45.00
Ask:
47.40
Spread: 2.40 (5.333%)
Market Cap: £180.26m
FTF Live PriceLast checked at - London Stock Exchange

Intraday Foresight Ent Share Chart

Portfolio Update

3 Apr 2023 08:00

Portfolio Update

Foresight Enterprise VCT PLCLEI: 213800MWJNR3WZZ3ZP42

Sale of portfolio company Innovation Consulting Group Limited (“GovGrant”) delivering a 4.5x cash-on-cash return and an IRR of 25% and the exit from Datapath Group Limited (“Datapath”) delivering an 11.7x cash-on-cash return and a 38% IRR for Foresight Enterprise VCT

The Board of Foresight Enterprise VCT Plc (“FEVCT” or the “Company”) is pleased to announce the sale of two portfolio companies since close of trading on 31 March 2023. The sale of GovGrant to Source Advisors, a US corporate buyer backed by BV Investment Partners, took place on 31 March 2023. GovGrant is one of the UK’s leading providers of R&D tax relief and patent box relief and other innovation services. The transaction will generate approximate gross proceeds of £6.8 million to FEVCT. When added to £0.7 million of cash returned to date, this implies a total cash-on-cash return of 4.5 times the capital of £1.65 million invested in October 2015; equivalent to an IRR of 25% per year.

Since FEVCT made its original investment in 2015, Foresight Group has supported GovGrant through a period of material growth during which it has supported the R&D activities of a growing number of customers. GovGrant’s high levels of service and innovative products, such as the growing patent box offering, have contributed to driving innovation in the UK economy. Foresight Group has taken a proactive approach to supporting the exceptional senior management team, all of whom were introduced to the business during the investment period.

The Board of the “Company” is also pleased to announce the exit on 31 March 2023 of portfolio company Datapath Group Limited (“Datapath”), a global leader in the provision of visual solutions. The transaction generated proceeds of £10.2 million at completion with an additional £2.3 million payable over the next 24 months. When added to £10.8 million of cash returned to date, this implies a total cash-on-cash return of 11.7 times the original investment; equivalent to an IRR of 38% since the initial investment in 2007.

Since the original investment, Foresight Group has supported Datapath through a period of material growth with revenues growing from approximately £7 million to £25 million. Datapath has developed a market leading hardware and software product suite for the delivery of multi-screen displays and video walls which are sold globally to a diverse customer base across a range of sectors.

Including payment of a 3.8p per share dividend paid in December 2022, the Company’s NAV per Ordinary Share was 63.7p as at 30 September 2022, to which the exit will add 2.0p, giving a pro forma NAV per Ordinary Share of 65.7p.

The sale represents FEVCT’s third and fourth exits in the last twelve months, following the exits of TFC Europe and Codeplay Software in 2022.

Raymond Abbott, Chair of Foresight Enterprise VCT said: “With Foresight’s support these two businesses have demonstrated strong growth and we are pleased to announce these two highly successful exits for the Company’s shareholders. Both investments are examples of how patient capital can help to unlock the growth potential of UK SMEs.”

For more information contact:

Gary Fraser, Foresight Group: 0203 667 8181

Date   Source Headline
16th Aug 20169:58 amRNSHolding(s) in Company
10th Aug 20157:30 amRNSSuspension - Foresight 4 VCT PLC
1st Sep 20097:00 amRNSTransaction in Own Shares & Total Voting Rights
29th Jul 20094:15 pmRNSChange of Adviser
14th Jul 20094:34 pmRNSInterim Management Statement
1st Jul 20097:00 amRNSTransaction in Own Shares & Total Voting Rights
19th Jun 20093:59 pmRNSAnnual Financial Report
2nd Jun 20098:53 amRNSIssue of Equity
20th May 20092:21 pmRNSIssue of Equity
29th Apr 200911:56 amRNSOffers for Subscription Extension
6th Apr 20095:47 pmRNSIssue of Equity - Replacement
6th Apr 20097:40 amRNSIssue of Equity
1st Apr 20093:03 pmRNSTotal Voting Rights
9th Mar 20098:05 amRNSIssue of Equity
3rd Mar 200910:19 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20092:20 pmRNSIssue of Equity
21st Jan 20093:02 pmRNSTransaction in Owns Shares and Total Voting Rights
19th Jan 20093:52 pmRNSInterim Management Statement
23rd Dec 200812:13 pmRNSChange of Adviser
22nd Dec 20082:14 pmRNSIssue of Equity
19th Dec 20083:07 pmRNSIssue of Equity
12th Dec 200810:40 amRNSIssue of Equity
10th Dec 200811:08 amRNSOffer for Subscription
3rd Dec 200810:23 amRNSTransaction in Own Shares and Total Voting Rights
30th Oct 200811:44 amRNSInterim Results
3rd Sep 20088:00 amRNSTransaction in Own Shares
21st Jul 20081:55 pmRNSInterim Management Statement
14th Jul 20083:56 pmRNSAnnual Information Update
27th Jun 20083:22 pmRNSFinal Results
1st May 20084:35 pmRNSIssue of Equity
7th Apr 20087:27 amRNSIssue of Equity
7th Apr 20087:00 amRNSIssue of Equity
31st Mar 20085:38 pmRNSIssue of Equity
6th Mar 20082:12 pmRNSIssue of Equity
3rd Mar 20083:27 pmRNSTransaction in Own Shares
27th Feb 20082:58 pmRNSIssue of Equity
13th Feb 20084:20 pmRNSIssue of Equity
13th Feb 200810:04 amRNSDoc re offer for subscription
23rd Jan 20088:25 amRNSInterim Management Statement
23rd Jan 20088:00 amRNSOffer for Subscription
20th Dec 20079:16 amRNSTransaction in Own Shares
17th Dec 20075:25 pmRNSEGM Statement
31st Oct 20078:19 amRNSInterim Results
3rd Sep 200712:13 pmRNSTransaction in Own Shares
9th Aug 20071:50 pmRNSAnnual Information Update
27th Jul 200710:11 amRNSTransaction in Own Shares
3rd Jul 200712:19 pmRNSInterim Management Statement
29th Jun 20073:28 pmRNSTransaction in Own Shares
11th Jun 20077:00 amRNSFinal Results
23rd Feb 200710:36 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.